JP Patent

JP7289265B2 — 脂質ナノ粒子ｍＲＮＡワクチン

Assigned to Acuitas Therapeutics Inc · Expires 2023-06-09 · 3y expired

What this patent protects

Patent listed against Leustatin.

Drugs covered by this patent

Leustatin (CLADRIBINE)

Patent Metadata

Patent number: JP7289265B2
Jurisdiction: JP
Classification: —
Expires: 2023-06-09
Drug substance claim: No
Drug product claim: No
Assignee: Acuitas Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.